HCC Current Controversies
-
Register
- Non-member - $30
- Member - $15
Already registered?
Log in now.
This recording is part of the SIO2021 Conference Recordings Bundle. Click here to purchase the full bundle and save!
| MODERATOR | Laura Crocetti, MD, PhD, EBIR |
| Is Biospy Dead in the Era of LIRADS? | Claude Sirlin, MD |
| Changing landscape of systemic therapy for HCC | Robin Kate Kelley, MD |
| Transplantation Triage | Andy Bonham, MD |
| Transarterial Therapies for HCC: Have We Reached Consensus?/Personalized Dosimetry for Y90 | Dave Liu, MD |
| Is SABR Definitive Treatment for HCC? | Laura Dawson, MD |
| Is Ablation Definitive Treatment for HCC? | Laura Crocetti, MD, PhD, EBIR |
| 957019 Delayed Treatment Response after Radiation Segmentectomy: Is 3 months follow up enough? | Shanmukha Srinivas, MD |
| Q&A | All Faculty |
Key:
Complete
Next
Failed
Available
Locked
